MMP9 and chronic obstructive pulmonary disease: Matrix metalloproteinase 9 (MMP9), as a disease marker in COPD has been supported by evidence (Dimic-Janjic et al., 2023),Its upregulation has also been shown to be associated with the degree of asthma inflammation (Yan et al., 2024).